United Kingdom
Search    
Include All CSL Behring Country Sites
For Healthcare Professionals
CSL Behring is committed to improving the quality of life for patients with rare and serious diseases. The company develops, manufactures and markets a range of products including:
Coagulation therapies
For rapid warfarin reversal, von Willebrand disease, haemophilia and congenital fibrinogen deficiency
Immunology therapies
For hereditary angioedema, immune deficiency disorders, and haemolytic disease of the newborn
Resource centre for healthcare professionals
For Patients
News